Publication | Closed Access

Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

TransplantationMarrow TransplantationGraft-versus-host Disease ProphylaxisStem Cell TransplantationHematologyImmunologyPost-transplantation CyclophosphamideTranslational ResearchGraft SurvivalAcceptable AlternativeImmunotherapyMedicineCell TransplantationGraft Rejection